相似文献
1
Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy.
Adv Mater. 2012 Feb 7;24(6):733-9. doi: 10.1002/adma.201103348. Epub 2012 Jan 2.
2
Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.
Biomacromolecules. 2006 Feb;7(2):597-603. doi: 10.1021/bm0506905.
3
Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.
Biomaterials. 2011 Nov;32(32):8319-27. doi: 10.1016/j.biomaterials.2011.07.039. Epub 2011 Aug 3.
4
In silico design of anti-atherogenic biomaterials.
Biomaterials. 2013 Oct;34(32):7950-9. doi: 10.1016/j.biomaterials.2013.07.011. Epub 2013 Jul 25.
5
Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture.
Int J Nanomedicine. 2007;2(4):697-705.
6
Ganglioside GM3 stimulates the uptake and processing of low density lipoproteins by macrophages.
Biochem Biophys Res Commun. 1991 May 31;177(1):582-7. doi: 10.1016/0006-291x(91)92023-d.
7
Fuel concentration dependent movement of supramolecular catalytic nanomotors.
Nanoscale. 2013 Feb 21;5(4):1315-8. doi: 10.1039/c2nr32976j.
8
Transport of macromolecules across arterial wall in the presence of local endothial injury.
J Theor Biol. 1979 Dec 21;81(4):685-711. doi: 10.1016/0022-5193(79)90277-7.
9
10
A recyclable supramolecular membrane for size-selective separation of nanoparticles.
Nat Nanotechnol. 2011 Mar;6(3):141-6. doi: 10.1038/nnano.2010.274. Epub 2011 Jan 23.
引用本文的文献
1
Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA-Peptide Nanoparticles toward Treating Mesothelioma.
Adv Mater. 2024 Jun;36(24):e2314367. doi: 10.1002/adma.202314367. Epub 2024 Apr 4.
2
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.
Transl Neurodegener. 2024 Jan 4;13(1):2. doi: 10.1186/s40035-023-00393-7.
3
CD36-Binding Amphiphilic Nanoparticles for Attenuation of Alpha Synuclein-Induced Microglial Activation.
Adv Nanobiomed Res. 2022 Jun;2(6). doi: 10.1002/anbr.202100120. Epub 2022 Mar 22.
4
Flash Technology-Based Self-Assembly in Nanoformulation: From Fabrication to Biomedical Applications.
Mater Today (Kidlington). 2021 Jan-Feb;42:99-116. doi: 10.1016/j.mattod.2020.08.019. Epub 2020 Nov 2.
5
Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy.
Drug Deliv. 2021 Dec;28(1):594-606. doi: 10.1080/10717544.2021.1898703.
6
Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation.
Front Bioeng Biotechnol. 2020 Feb 21;8:112. doi: 10.3389/fbioe.2020.00112. eCollection 2020.
7
Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis.
Nanomaterials (Basel). 2018 Feb 2;8(2):84. doi: 10.3390/nano8020084.
8
Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.
Acta Biomater. 2017 Jul 15;57:85-94. doi: 10.1016/j.actbio.2017.05.029. Epub 2017 May 15.
9
Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.
Biomaterials. 2016 Dec;111:179-189. doi: 10.1016/j.biomaterials.2016.10.001. Epub 2016 Oct 4.
10
Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion.
Biomaterials. 2016 Apr;84:219-229. doi: 10.1016/j.biomaterials.2015.12.033. Epub 2016 Jan 4.
本文引用的文献
1
Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.
Biomaterials. 2011 Nov;32(32):8319-27. doi: 10.1016/j.biomaterials.2011.07.039. Epub 2011 Aug 3.
2
Fluorescent polymeric nanoparticles: aggregation and phase behavior of pyrene and amphotericin B molecules in nanoparticle cores.
Small. 2010 Dec 20;6(24):2907-14. doi: 10.1002/smll.201001199.
3
Strategies in the design of nanoparticles for therapeutic applications.
Nat Rev Drug Discov. 2010 Aug;9(8):615-27. doi: 10.1038/nrd2591. Epub 2010 Jul 9.
4
Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.
Acta Biomater. 2010 Aug;6(8):3081-91. doi: 10.1016/j.actbio.2010.02.019. Epub 2010 Feb 17.
5
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles.
Mol Pharm. 2010 Feb 1;7(1):291-8. doi: 10.1021/mp900245h.
6
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Expert Opin Drug Deliv. 2009 Aug;6(8):865-78. doi: 10.1517/17425240902932908.
7
Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.
Biomacromolecules. 2009 Jun 8;10(6):1381-91. doi: 10.1021/bm8014522.
8
Nanoparticles in cellular drug delivery.
Bioorg Med Chem. 2009 Apr 15;17(8):2950-62. doi: 10.1016/j.bmc.2009.02.043. Epub 2009 Feb 26.
9
Impact of nanotechnology on drug delivery.
ACS Nano. 2009 Jan 27;3(1):16-20. doi: 10.1021/nn900002m.
10
Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density.
Biomacromolecules. 2008 Oct;9(10):2705-11. doi: 10.1021/bm8002013. Epub 2008 Aug 30.
Zotero 插件